AVAH Stock Overview
A diversified home care platform company, provides pediatric and adult healthcare services in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Aveanna Healthcare Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.61 |
| 52 Week High | US$3.07 |
| 52 Week Low | US$0.85 |
| Beta | 2.03 |
| 1 Month Change | 12.02% |
| 3 Month Change | 17.57% |
| 1 Year Change | 99.24% |
| 3 Year Change | -78.38% |
| 5 Year Change | n/a |
| Change since IPO | -77.36% |
Recent News & Updates
Recent updates
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 12
Investors Aren't Buying Aveanna Healthcare Holdings Inc.'s (NASDAQ:AVAH) Revenues
Apr 15An Intrinsic Calculation For Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Suggests It's 47% Undervalued
Jan 23Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Surges 64% Yet Its Low P/S Is No Reason For Excitement
Dec 11Aveanna Healthcare Holdings Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates
Aug 13Capital Allocation Trends At Aveanna Healthcare Holdings (NASDAQ:AVAH) Aren't Ideal
Jul 20Some Investors May Be Worried About Aveanna Healthcare Holdings' (NASDAQ:AVAH) Returns On Capital
Mar 14Aveanna Healthcare Holdings' (NASDAQ:AVAH) Returns On Capital Not Reflecting Well On The Business
Nov 13Aveanna Healthcare - In Need Of Help
Sep 26Aveanna Healthcare Holdings Non-GAAP EPS of $0.03 misses by $0.04, revenue of $443M misses by $4.02M
Aug 11Aveanna Healthcare cuts 2022 guidance, expects weak Q2 results due to labor issues
Jul 19Aveanna Contends With Labor And Supply Chain Challenges In Inflationary Environment
Jun 21Aveanna Healthcare Holdings (NASDAQ:AVAH) Could Be Struggling To Allocate Capital
Jun 15Aveanna Healthcare: I Still Can't Care For It
Jan 27Is Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Trading At A 43% Discount?
Nov 24Aveanna Healthcare: Compelling Longer-Term Growth Story Remains Intact
Sep 14Help at Home is said to explore IPO as soon as this year
Jun 09Aveanna Healthcare - Home Care Play
May 02Home-health firm Aveanna Healthcare cuts IPO’s price range to $12-13/share
Apr 28Shareholder Returns
| AVAH | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -6.8% | 0.3% | -0.6% |
| 1Y | 99.2% | 1.7% | 22.2% |
Return vs Industry: AVAH exceeded the US Healthcare industry which returned 1.7% over the past year.
Return vs Market: AVAH exceeded the US Market which returned 22.2% over the past year.
Price Volatility
| AVAH volatility | |
|---|---|
| AVAH Average Weekly Movement | 7.5% |
| Healthcare Industry Average Movement | 6.5% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: AVAH has not had significant price volatility in the past 3 months.
Volatility Over Time: AVAH's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 33,500 | Jeff Shaner | www.aveanna.com |
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS).
Aveanna Healthcare Holdings Inc. Fundamentals Summary
| AVAH fundamental statistics | |
|---|---|
| Market cap | US$502.11m |
| Earnings (TTM) | -US$113.70m |
| Revenue (TTM) | US$1.92b |
0.3x
P/S Ratio-4.4x
P/E RatioIs AVAH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AVAH income statement (TTM) | |
|---|---|
| Revenue | US$1.92b |
| Cost of Revenue | US$1.32b |
| Gross Profit | US$596.82m |
| Other Expenses | US$710.52m |
| Earnings | -US$113.70m |
Last Reported Earnings
Mar 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.59 |
| Gross Margin | 31.09% |
| Net Profit Margin | -5.92% |
| Debt/Equity Ratio | -1,080.5% |
How did AVAH perform over the long term?
See historical performance and comparison